{{Rsnum
|rsid=10482633
|Gene=NR3C1
|Chromosome=5
|position=143370968
|Orientation=plus
|GMAF=0.107
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=NR3C1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 62.8 | 34.5 | 2.7
| HCB | 99.3 | 0.7 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 83.7 | 14.3 | 2.0
| ASW | 82.5 | 15.8 | 1.8
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 71.3 | 25.7 | 3.0
| LWK | 78.2 | 20.9 | 0.9
| MEX | 82.5 | 17.5 | 0.0
| MKK | 74.8 | 23.2 | 1.9
| TSI | 56.4 | 38.6 | 5.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs10482633
|Name_s=
|Gene_s=NR3C1
|Feature=
|Evidence=PubMed ID:19365399
|Annotation=This variant is associated with response to escitalopram and nortriptyline in a study of 760 adult patients with moderate-to-severe depression.
|Drugs=escitalopram; nortriptyline
|Drug Classes=
|Diseases=Depression
|Curation Level=Curated
|PharmGKB Accession ID=PA164924623
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10482633
|overall_frequency_n=8
|overall_frequency_d=128
|overall_frequency=0.0625
|n_genomes=8
|n_genomes_annotated=0
|n_haplomes=8
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}